DAWN – Day One Biopharmaceuticals, Inc.
Float Short %
15.11
Margin Of Safety %
Put/Call OI Ratio
0.26
EPS Next Q Diff
-0.02
EPS Last/This Y
-0.15
EPS This/Next Y
0.42
Price
7.1
Target Price
23.56
Analyst Recom
1.2
Performance Q
6.43
Relative Volume
0.44
Beta
-1.26
Ticker: DAWN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | DAWN | 6.76 | 0.11 | 0.00 | 3716 |
| 2025-08-18 | DAWN | 6.8 | 0.19 | 0.00 | 2149 |
| 2025-08-19 | DAWN | 6.82 | 0.18 | 0.23 | 2299 |
| 2025-08-20 | DAWN | 6.82 | 0.17 | 0.00 | 2355 |
| 2025-08-21 | DAWN | 6.99 | 0.17 | 0.00 | 2298 |
| 2025-08-22 | DAWN | 7.2 | 0.17 | 0.10 | 2294 |
| 2025-08-25 | DAWN | 6.97 | 0.16 | 0.38 | 2512 |
| 2025-08-26 | DAWN | 7.47 | 0.16 | 0.00 | 2533 |
| 2025-08-27 | DAWN | 7.59 | 0.16 | 0.70 | 2572 |
| 2025-08-28 | DAWN | 7.58 | 0.31 | 0.01 | 3592 |
| 2025-08-29 | DAWN | 7.5 | 0.30 | 0.00 | 3638 |
| 2025-09-02 | DAWN | 7.38 | 0.30 | 0.00 | 3642 |
| 2025-09-03 | DAWN | 7.47 | 0.30 | 0.03 | 3667 |
| 2025-09-04 | DAWN | 7.41 | 0.29 | 0.00 | 3790 |
| 2025-09-05 | DAWN | 7.55 | 0.29 | 0.00 | 3800 |
| 2025-09-08 | DAWN | 7.48 | 0.29 | 0.00 | 3803 |
| 2025-09-09 | DAWN | 7.41 | 0.29 | 0.00 | 3822 |
| 2025-09-10 | DAWN | 7.26 | 0.29 | 0.02 | 3823 |
| 2025-09-11 | DAWN | 7.38 | 0.26 | 0.00 | 4083 |
| 2025-09-12 | DAWN | 7.11 | 0.26 | 0.29 | 4087 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | DAWN | 6.76 | -179.8 | - | -1.19 |
| 2025-08-18 | DAWN | 6.80 | -173.3 | - | -1.19 |
| 2025-08-19 | DAWN | 6.82 | -173.3 | - | -1.19 |
| 2025-08-20 | DAWN | 6.81 | -173.3 | - | -1.19 |
| 2025-08-21 | DAWN | 6.99 | -173.3 | - | -1.19 |
| 2025-08-22 | DAWN | 7.20 | -173.3 | - | -1.19 |
| 2025-08-25 | DAWN | 6.98 | -173.3 | - | -1.19 |
| 2025-08-26 | DAWN | 7.46 | -173.3 | - | -1.19 |
| 2025-08-27 | DAWN | 7.59 | -173.3 | - | -1.19 |
| 2025-08-28 | DAWN | 7.59 | -173.3 | - | -1.19 |
| 2025-08-29 | DAWN | 7.50 | -173.3 | - | -1.19 |
| 2025-09-02 | DAWN | 7.38 | -173.3 | - | -1.17 |
| 2025-09-03 | DAWN | 7.47 | -173.3 | - | -1.17 |
| 2025-09-04 | DAWN | 7.40 | -173.3 | - | -1.17 |
| 2025-09-05 | DAWN | 7.55 | -173.3 | - | -1.17 |
| 2025-09-08 | DAWN | 7.47 | -173.3 | - | -1.17 |
| 2025-09-09 | DAWN | 7.41 | -173.3 | - | -1.17 |
| 2025-09-10 | DAWN | 7.26 | -173.3 | - | -1.17 |
| 2025-09-11 | DAWN | 7.37 | -173.3 | - | -1.17 |
| 2025-09-12 | DAWN | 7.10 | -173.3 | - | -1.17 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | DAWN | -0.18 | -3.02 | 13.13 |
| 2025-08-18 | DAWN | -0.18 | -7.01 | 13.27 |
| 2025-08-19 | DAWN | -0.17 | -7.01 | 13.27 |
| 2025-08-20 | DAWN | -0.27 | -7.01 | 13.27 |
| 2025-08-21 | DAWN | -0.27 | -7.01 | 13.27 |
| 2025-08-22 | DAWN | -0.20 | -7.01 | 13.27 |
| 2025-08-25 | DAWN | -0.20 | -9.17 | 13.27 |
| 2025-08-26 | DAWN | -0.20 | -9.17 | 13.27 |
| 2025-08-27 | DAWN | -0.20 | -9.17 | 15.68 |
| 2025-08-28 | DAWN | -0.20 | -9.17 | 15.68 |
| 2025-08-29 | DAWN | -0.20 | -9.17 | 15.68 |
| 2025-09-02 | DAWN | -0.20 | -9.48 | 15.68 |
| 2025-09-03 | DAWN | -0.20 | -9.48 | 15.68 |
| 2025-09-04 | DAWN | -0.20 | -9.48 | 15.68 |
| 2025-09-05 | DAWN | -0.20 | -9.48 | 15.68 |
| 2025-09-08 | DAWN | -0.20 | -9.37 | 15.68 |
| 2025-09-09 | DAWN | -0.20 | -9.37 | 15.68 |
| 2025-09-10 | DAWN | -0.20 | -9.37 | 15.68 |
| 2025-09-11 | DAWN | -0.20 | -9.37 | 15.11 |
| 2025-09-12 | DAWN | -0.20 | -9.37 | 15.11 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.29
Avg. EPS Est. Current Quarter
-0.28
Avg. EPS Est. Next Quarter
-0.31
Insider Transactions
-0.2
Institutional Transactions
-9.37
Beta
-1.26
Average Sales Estimate Current Quarter
38
Average Sales Estimate Next Quarter
41
Fair Value
Quality Score
41
Growth Score
29
Sentiment Score
3
Actual DrawDown %
75.3
Max Drawdown 5-Year %
Target Price
23.56
P/E
Forward P/E
PEG
P/S
3.89
P/B
1.58
P/Free Cash Flow
EPS
-0.91
Average EPS Est. Cur. Y
-1.17
EPS Next Y. (Est.)
-0.75
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-50.63
Relative Volume
0.44
Return on Equity vs Sector %
-45.5
Return on Equity vs Industry %
-32.3
EPS 1 7Days Diff
EPS 1 30Days Diff
0.17
EBIT Estimation
Day One Biopharmaceuticals, IncSector: Healthcare
Industry: Biotechnology
Employees: 182
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading